Navigation Links
UNLV, Sen. Reid Announce $20 Million NIH grant to support clinical health research
Date:9/18/2013

LAS VEGAS -- The University of Nevada, Las Vegas (UNLV) and Nevada Senator Harry Reid announced a five-year, $20.3 million grant awarded to UNLV from the National Institutes of Health (NIH) to lead a health research network of 13 universities across the Mountain West. The University of Nevada School of Medicine will partner on the grant.

The Clinical Translational Research Infrastructure Network (CTR-IN) will expand the capacity of partner institutions across seven states to put clinical research into practice to address regional health concerns including access to care, cancer, obesity, diabetes, and cardiovascular and infectious diseases.

"This grant will be a game-changer for Nevada and the entire region," said program director Dr. Robert D. Langer, a physician and epidemiologist with more than 25 years of related research experience. Langer holds faculty appointments at UNLV's School of Allied Health Sciences and the University of Nevada School of Medicine.

"We will now have the means to address the unique health needs of people in the Mountain West, which covers one third of the U.S. and faces tremendous healthcare delivery challenges," said Langer. "While we've been successful in building basic science research, until now we've had a tough time building traction for research that can help everyday people. This grant will help us change that."

Partner institutions will share resources and expertise to centralize services for researchers. This will improve research capacity at the institutional level and increase the likelihood for future independent NIH-funded research studies. Services/resources include:

  • Pilot grants of one to two years per award for clinical and translational research.
  • A virtual clinical translational science center hosted at UNLV and tailored to the needs of the 13 partner institutions.
  • Mini-sabbaticals and visiting scholar awards to promote greater collaboration.
  • Biostatistical support, mentorship, educational opportunities, and editorial and administrative support.
  • Annual meetings focused on themes drawn from the health issues of the region.

"This is wonderful news for UNLV and the University of Nevada School of Medicine," said Nevada Senator Harry Reid. "They led a collaborative effort to develop a proposal to improve research and medical care across Nevada and parts of the West. I strongly supported this effort and urged the National Institutes of Health to select this grant. These federal grant funds will help Nevada and our universities, research and medical facilities better address some of our most difficult health care challenges."

Though most CTR-IN universities have successful programs in basic science, they lack capacity in clinical or bench-to-bedside research -- what the NIH refers to as translational research -- and have limited resources to support faculty conducting this type of work. Only three partner institutions have medical schools and the two outside of Nevada -- the Universities of New Mexico and Hawaii -- have NIH-funded research centers to provide additional support to CTR-IN partners. With this grant, Nevada achieves similar leadership capability.

For UNLV, the grant is part of an expected major build-out in health sciences over the next five years and supports the university's goal to attain status as a Tier 1 institution.

"Our region must improve the quality of healthcare available to all Nevadans, and we have an incredible opportunity through this grant to build clinical and related research capacity in Southern Nevada and across the Mountain West," said UNLV President Neal Smatresk. "This program will allow UNLV and our partners to more readily support the rapid growth of medical advancements by teaming up to solve the unique health issues affecting our region."

Grant funding comes from the NIH Institutional Development Award (IDeA) Program. IDeA grants are intended to enhance the caliber of scientific faculty at research institutions in historically underfunded IDeA-eligible states, thereby attracting more promising faculty and students.

The CTR-IN will further this goal among the 13 partnering universities:

The University of Nevada, Las Vegas; University of Nevada, Reno (through the University of Nevada School of Medicine); University of Alaska, Anchorage; University of Alaska, Fairbanks; University of Hawaii at Manoa; Boise State University; Idaho State University; University of Idaho; Montana State University; University of Montana; University of New Mexico; New Mexico State University; and the University of Wyoming.

"We are extraordinarily pleased to partner with UNLV in a major clinical research grant that will contribute to improving the quality of health and healthcare across Nevada and the western states," said Thomas L. Schwenk, MD, dean of the University of Nevada School of Medicine and vice president of the University of Nevada, Reno, Division of Health Sciences.

UNLV will coordinate the grant through its School of Allied Health Sciences. Each of the member institutions will provide administrative, personnel and infrastructure support.


'/>"/>

Contact: Tony Allen
tony.allen@unlv.edu
702-895-0893
University of Nevada, Las Vegas
Source:Eurekalert

Related biology news :

1. Alnylam and UMass Medical School announce Tuschl I patent upheld in European opposition proceedings
2. Modern Mobility Aids, Inc. Announces a Revised Agreement for the Acquisition of Lumigene
3. ChromaDex® Announces Financial Results for the Year Ended 2011
4. Improved Authentication and Confidentiality Protection. ICAP Patent Brokerage Announces for Auction Important Patents in Data Encryption and Document Security
5. MARC travel awards announced for EB 2012
6. MARC travel award announced for the 2012 ASCI/AAP Joint Meeting
7. FirstMark Announces New Hire Jay Houtman as Southeast Regional Sales Manager
8. Global Information Inc. Announces Discounted Conference Registration For Bio-IT World Asia and Biodetection Technologies 2012
9. Genzyme/ACMG Foundation Genetics Training Award in Clinical Biochemical Genetics announced
10. 2012 ACMG Foundation/Signature Genomic Laboratories Travel Award winner announced
11. Botanical institutions announce plans to create first online World Flora
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/11/2017)... April 11, 2017 NXT-ID, Inc. (NASDAQ: ... company, announces the appointment of independent Directors Mr. Robin ... its Board of Directors, furthering the company,s corporate governance and ... Gino Pereira ... look forward to their guidance and benefiting from their considerable ...
(Date:4/4/2017)... 4, 2017   EyeLock LLC , a leader ... United States Patent and Trademark Office (USPTO) has issued ... linking of an iris image with a face image ... the company,s 45 th issued patent. ... timely given the multi-modal biometric capabilities that have recently ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
Breaking Biology News(10 mins):
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... ... scaffold technology, today announced the election of Paul Hermes, Entrepreneur in Residence at ... , Biorez has developed a proprietary, tissue-engineered scaffold for anterior cruciate ligament ...
(Date:9/20/2017)... ... September 20, 2017 , ... Proscia Inc. , ... a provider of whole slide imaging solutions, are hosting a pre-conference workshop at ... “Successfully Deploying a Best-in-Class Strategy for Digital Pathology,” will feature Proscia CEO, David ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... the most dangerous step of sample prep for metals digestion—the addition of acids ... at an affordable price. The system is ideal for any laboratory performing their ...
(Date:9/19/2017)... ... September 19, 2017 , ... One of ... to be eliminated, said Lyle Probst, President, CEO and Founder of ExcitePCR ... than other pathogen detection solutions, Probst said, “Sample preparation takes place inside our ...
Breaking Biology Technology: